Latest News by Industry
IGM Biosciences, Inc. [IGMS] has reported fiscal Q1 loss of $59.30 million.
On a per-share basis, the DE based company said its diluted earnings are $1.33.
The Pharmaceutical Preparations firm posted revenue of $0.52 million in this period.
Also Read: